DNMT3A and acute myeloid leukemia: DNMT3A mutation was found to be present in highly purified hematopoietic stem cells in AML patients, and stem cells bearing DNMT3A mutation showed a multilineage repopulation advantage over stem cells without DNMT3A mutation [34].